QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis

NCT00581997 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class

Stopped Concerns about risk of bronchoscopy procedure in the selected patient population and frequency of SAEs observed to date.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals